(Q43511625)

24 November 2017

Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse (English)

1 reference

24 November 2017

Araki T

1

1 reference

24 November 2017

Mikami T

2

1 reference

24 November 2017

Tanji H

3

1 reference

24 November 2017

Matsubara M

4

1 reference

24 November 2017

Imai Y

5

1 reference

24 November 2017

Mizugaki M

6

1 reference

24 November 2017

Itoyama Y

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

European Journal of Pharmaceutical Sciences

24 November 2017

1 reference

24 November 2017

12

1 reference

24 November 2017

3

1 reference

24 November 2017

231-238

1 reference

Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Free radicals and MPTP-induced selective destruction of substantia nigra compacta neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Presynaptic and postsynaptic D1 dopamine receptors in the nigrostriatal system of the rat brain: a quantitative autoradiographic study using the selective D1 antagonist [3H]SCH 23390

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Expression of gamma-aminobutyric acid immunoreactivity in reactive astrocytes after ischemia-induced injury in the adult forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Effect of Unilateral Perinatal Hypoxic-Ischemic Brain Injury in the Rat on Dopamine D1and D2Receptors and Uptake Sites: A Quantitative Autoradiographic Study

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Dopamine D-1 receptors in the parkinsonian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900170-6

7 January 2021

10.1016/S0928-0987(00)00170-6

Identifiers

DOI

1 reference

24 November 2017

1 reference